Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises Additional $1.2M in Debt Placement

NEW YORK (GenomeWeb News) – GeneNews today said that it has raised an additional C$1,475,210 (US$1.2 million) through the third tranche of a private placement of debentures.

The total amount of debentures sold to date in the offering is C$3,252,342. GeneNews said that more than one quarter of the debentures were purchased by members of management and the board of directors.

The Toronto-based firm said that proceeds from the placement would be used for general working capital purposes and continued marketing of its ColonSentry test in Canada, as well as for pre-launch activities for the test in the US and Asia.

GeneNews said that it has accepted subscriptions for five-year, 15 percent redeemable convertible secured debentures. The 15 percent annual interest will be paid upon the earlier of maturity, conversion, or redemption of the debentures.

Each purchaser of a debenture will also receive one warrant for every C$.25 of principal amount of their debenture. Each of those warrants is exercisable into GeneNews common shares for a period of 36 months following the date of issuance at a price of C$.25 per common share.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.